local_hospital

Spitalul De Psihiatrie 'Elisabeta Doamna' Galati

Address
Traian Street No 290, 800179 Galati, Romania

Spitalul De Psihiatrie 'Elisabeta Doamna' Galati - Psychiatric Research Center

Spitalul De Psihiatrie 'Elisabeta Doamna' Galati is a specialized psychiatric research institution conducting advanced clinical trials in mood disorders, psychotic conditions, and neurodegenerative diseases. The center demonstrates expertise in complex psychiatric conditions requiring sophisticated diagnostic and treatment approaches, with particular emphasis on medication trials for severe mental health disorders.

  • Major Depressive Disorder with moderate-to-severe anhedonia, investigating adjunctive therapies and relapse prevention strategies
  • Bipolar I Disorder with acute mania and manic episodes, evaluating novel pharmacological interventions
  • Psychosis associated with Alzheimer's Disease, focusing on behavioral and psychiatric manifestations in neurodegenerative conditions

The research center is actively involved in placebo-controlled, double-blind trials evaluating next-generation psychiatric medications. Their participation in multinational studies examining conditions such as treatment-resistant depression, acute manic episodes, and neuropsychiatric symptoms of dementia positions them as a key contributor to advancing psychiatric pharmacotherapy and understanding complex mental health conditions in both younger adults and elderly populations.

Site Overview

assignment
5
connected trials
corporate_fare
5
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
5
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
5
Outperforms 62% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
5sponsors
Outperforms 69% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul De Psihiatrie 'Elisabeta Doamna' Galati

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicenter, placebo-controlled, randomized, double-blind, parallel-group comparison trial to investigate the efficacy and safety of brexpiprazole once-weekly (QW) formulation in patients with acute schizophreniaOtsuka Pharmaceutical Co. Ltd.Phase IIIRecruitingJul 2024

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
4-Hydroxy-N-Desmethyltamoxifen1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.